Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply
JAMA Dermatology · 2024
DOI: 10.1001/jamadermatol.2024.0876 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Marie-Charlotte Brüggen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Herpesvirus 6, Human, Roseolovirus Infections, Virus Activation, Drug Hypersensitivity Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- Christine Kühne Center for Allergy Research and Education CK-CARE, Davos, Switzerland.
- Faculty of Medicine, University of Zurich, Zurich, Switzerland.
- Reference Center for Toxic Bullous Diseases and Severe Drug Reactions, Créteil, France.
- Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Henri Mondor hospital, Créteil, France.
- Univ Paris Est Créteil EpiDermE, Créteil, France.
Zitieren
APA
Brüggen, M. C., & Ingen-Housz-Oro, S. (2024). Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.0876
Vancouver
Brüggen MC, Ingen-Housz-Oro S. Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.0876
BibTeX
@article{Brggen2024,
author = {Brüggen, Marie-Charlotte and Ingen-Housz-Oro, Saskia},
title = {Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply},
journal = {JAMA Dermatology},
year = {2024},
doi = {10.1001/jamadermatol.2024.0876}
}
EUVIMED